Monthly Archives: March 2017

SHAREHOLDER NOTICE: Lundin Law PC Announces a Class Action Lawuit Against Gigamon Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 20, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Gigamon Inc., (“Gigamon” or the “Company”) (NYSE: GIMO). Investors, who purchased or otherwise acquired Gigamon shares between October 27, 2016 and January 17, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 28, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, please click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The investigation is centered on whether Gigamon and some of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

Gigamon is involved with products and services that provide customers visibility and power over network traffic for corporations and service providers in the United States, as well as various international locations.

On January 18, 2017, Gigamon announced early fourth quarter and fiscal year 2016 results. In the report, Gigamon revealed that fourth quarter revenue for the period ending December 31, 2016 would be significantly less compared to the guidance last year.

The Company claimed fourth quarter revenue fell short because of “lower than expected product booking,” as well as the decision of existing customers to hold “purchasing decisions into 2017.” When this information was revealed to the public, the value of Gigamon stock fell over 28%, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 457708

EarthWater Selected to Present at the Texas Consumer Venture Forum

AUSTIN, TX / ACCESSWIRE / March 20, 2017 / EarthWater (www.EarthWater.com), a manufacturer of high alkaline mineral infused beverage products under brands FulHum and ZenFul, is excited to announce its role in the Texas Consumer Venture Forum produced by Ten Capital Group (www.tencapital.group) on March 21st, 2017 at the Palmer Events Center in Austin, TX.

The invitation-only event will bring together pre-qualified Texas based consumer product groups, brewery, winery, and spirits with Institutional and Accredited Investors at the Palmer Events Center (www.palmereventscenter.com) in Austin, TX, for a full day of presentations, networking, and, of course, delicious food and EarthWater!

Cash Riley Jr., President of EarthWater, said, “For a city as vibrant and innovative as Austin, it’s so great to be a part of an event and movement that brings the right industry people in your circle, something you can’t normally find on a day-to-day basis.”

Texas Consumer Venture Forum is produced by TEN Capital Group, formerly known as Texas Growth Capital Forum, a financial services company that facilitates company and investor connections, shares data and analytics, and puts on three growth equity conferences a year – one focused on healthcare, one on tech, and this exciting consumer venture forum.

About EarthWater Inc.

EarthWater, Inc. (www.earthwater.com) is a health and wellness company that manufactures all-natural products that boost your body’s immunity, including beverages, liquid concentrates, and gummies under the brands FulHum (www.drinkfulhum.com) and Zenful (www.drinkzenful.com), which are 100% natural, proprietary blends of organic Fulvic and Humic complexes. All EarthWater products are available online through Amazon. For more information, email info@earthwater.com.

About Ten Capital Group

The Texas Entrepreneur Networks (TEN) helps startups and growth companies raise funding from investors across the state of Texas. Typically, companies raise between $5K and $5M using the TEN Funding Portal. Once companies have raised their funding, we provide ongoing support for investor relations. For more information, visit: www.tencapital.group.

SOURCE: EarthWater, Inc.

ReleaseID: 457617

AK Steel Holding and United States Steel Advance on Positive Investment Ratings

NEW YORK, NY / ACCESSWIRE / March 20, 2017 / AK Steel Holding and United States Steel both were rewarded by investors for their stock market performance and increased financial management. Both companies diversify in the manufacture and production of steel products. The announcement by the Federal Reserve that it would increase interest rates did not have any negative impact on either of the companies, indicating that the Fed increase will have little, if any, effect on the manufacturing industry. AK Steel Holding was a beneficiary of its parent company’s positive news.

RDI Initiates
Coverage:

AK Steel Holding
Corporation https://ub.rdinvesting.com/news/?ticker=AKS

United States Steel
Corporation https://ub.rdinvesting.com/news/?ticker=X

AK Steel Holding found itself settling to close at $8.31 a share after hitting an early morning high of $8.53. It closed up 6 cents. The news on its rating by investment rating services is a mixed bag this year so far, with J P Morgan downgrading the stock to a “neutral” level from “overweight” rating, Credit Suisse downgrading it to “neutral” and Citi downgrading it to “sell”, during the month of January. In contrast, a number of investment firms like Jafferies Group reiterating “buy” rating on the stock since January and Deutsche Bank AG is maintaining “Hold” ratings since early December last year. If we look at the investors activities of the last quarter, institutions still holding over 82 percent of the company’s share with ratio of total number of increased positions to the total number of decreased positions in the quarter standing nearly 4 to 1. While latest positive news is coming Moody’s Investors Service for upgrading the Corporate Family Rating (CFR) of the company from B3 to B2 on March 9th of this year. Moody also commented that the AK Steel’s outlook was “stable.” Helped by cost cutting measures, AK Steel has posted better results in January for the fourth quarter of 2016 with net loss of $0.22 a share and adjusted earnings of 0.25 a share on revenue of $1.42 billion, which is better than the consensus estimate of earnings $0.06. The company will release result for the first quarter on April 25th.

Access RDI’s AK Steel Holding Research Report at: https://ub.rdinvesting.com/news/?ticker=AKS

United States Steel (U.S. Steel) closed flat at $37.29 a share at the close on Friday. It was announced that Cowen and Company had upgraded its recommendation on U. S. Steel to “outperform” from “market perform” in February with the expectations of higher positive earnings surprise this year, whereas post its fourth quarter result, J P Morgan raised price target from $37 to $39 and Bank of America raised its rating from “neutral” to “buy”. However, a number of technical indicators show that the company’s stock is either overbought or overvalued, recommending that caution be used as the stock continues its climb. On November 2nd of last year, its stock price was at $17.82 and it had a steady rise since then, reaching a 52 week high of $41.57 on February 21st of this year. U.S. Steel has reported a net loss of $0.61 a share and adjusted earnings of $0.27 a share on revenue of $2.65 billion for the fourth quarter of 2016, crushing estimated range of $0.01 to $0.04 a share of adjusted earnings by consensus, from different surveys.

Access RDI’s United States Steel Research Report at: https://ub.rdinvesting.com/news/?ticker=X

Our Actionable Research on AK Steel Holding Corporation (NYSE: AKS) and United States Steel Corporation (NYSE: X) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at
www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 457689

Are Chesapeake Energy and Southwestern Energy Impacted by the Fed’s Rate Increase?

NEW YORK, NY / ACCESSWIRE / March 20, 2017 / Chesapeake Energy and Southwestern Energy are two stocks that are favorites for many investors, both expecting increases in revenues over the next 12 months. Despite the positive outlooks from investors, both stocks dropped after the Federal Reserve announced its interest rate hike, a point where the general market began to recover from its opening losses. Whether management issues are contributory factors to the decline remains to be seen.

RDI Initiates
Coverage:

Chesapeake Energy
Corporation https://ub.rdinvesting.com/news/?ticker=CHK

Southwestern Energy
Company https://ub.rdinvesting.com/news/?ticker=SWN

Chesapeake Energy fell 16 cents a share on Friday to close at $5.29 a share. The stock has a generally positive rating from investment rating firms, with a majority recommending “hold” though this is a qualified hold. Notably, Chesapeake was the first company to use fracking to drill for natural gas reserves, but the plunge in natural gas prices paralleled the company’s declining investment in fracking. The company’s founder, Aubrey McClendon, died one year ago and the company continues to search for a direction. Despite the downturns, insider and regular buying of the stock continues. Chesapeake has reported a net loss of $6.45 a share on revenue of $7.9 billion for the year 2016 as compared to loss of $22.43 a share on revenue of $12.8 billion reported for the year 2015. The company currently has about $13 billion in assets but almost $10 billion in debt and it expects higher capex spending in the year 2017 reflecting management’s confidence in achieving free cash flow neutrality by 2018.

Access RDI’s Chesapeake Energy Research Report at: https://ub.rdinvesting.com/news/?ticker=CHK

Southwestern energy was down 12 cents a share to close at $7.63 a share on Friday. Company’s stock received numbers of ratings changes post it’s fourth quarter and full year 2016 result on February 23. Analysts at Citi upgraded stock from “neutral” to “buy” and Jefferies group LLC upgraded it to “hold” from “underperform”. Other firms such as KLR group and Raymond James reiterated their ratings of “buy” and “hold” for the company respectively. Whereas Sanford C. Bernstein has downgraded its rating to “market perform” from “outperform”. Despite reporting a loss of $2.75 billion or $6.32 a share on revenue of $2.44 billion for the year 2016, the company is confident on its West Virginia Assets on slowly recovering natural gas prices, while the firm now controls virtually all Marcellus and Utica shale drilling and fracking in Ohio and Brooke countries. Southwestern ended year 2016 with 5,253 billions of cubic feet equivalent (Bcfe) of proved reserves, down from 6,215 Bcfe at the end of year 2015 and the company anticipates capex spending between $1.175 billion to $1.275 billion for 2017.

Access RDI’s Southwestern Energy Research Report at: https://ub.rdinvesting.com/news/?ticker=SWN

Our Actionable Research on Chesapeake Energy Corporation (NYSE: CHK) and Southwestern Energy Company (NYSE: SWN) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at
www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 457690

Today’s Research Reports on Stocks to Watch: Seadrill and Transocean

NEW YORK, NY / ACCESSWIRE / March 20, 2017 / Seadrill and Transocean are companies whose commitment to offshore oil and natural gas drilling is not paying off as expected. The failure of requests for new drilling to materialize has unsettled both companies’ stock prices. The oil industry was seeing oil prices approach $50 a barrel earlier in the year, BUT Saudi Arabia announced it will be raising is production levels to 10 million barrels per day, resulting in oil prices taking a step backward. Seadrill and Transocean may be just two example of the impact of low energy prices that have been advantageous for consumers.

RDI Initiates
Coverage:

Seadrill Ltd https://ub.rdinvesting.com/news/?ticker=SDRL

Transocean Ltd. https://ub.rdinvesting.com/news/?ticker=RIG

Seadrill closed down 4 cents a share on Friday, at a price of $1.49 a share. This stock price is in the stages of a continued decline as it indicated in its shareholder report that the company’s attempts at financial restructuring are continuing, but that in the event such restructuring is not possible, the company has “contingency plans, including potential schemes of arrangement or chapter 11 proceedings.” In other words, bankruptcy is a definite possibility. The skinny is that while short term debt has been competently handled by management, the long term debt can be crushing. The company engages in drilling offshore oil rigs and currently has 1.4 billion in cash reserves, enough for it to operate until the end of the current year. But those long term debts loom large and will require generous debtors to continue to extend the payments on the loans, as the company still has nearly $3.4 billion of debt due starting from April 30th, and an additional it lost $2 billion in future revenues thanks to expiring contracts. Connected with that long term debt is a young fleet of tankers that is a competitive advantage – if it can find willing customers to hire them.

Access RDI’s Seadrill
Research Report at: https://ub.rdinvesting.com/news/?ticker=SDRL

Transocean stock dropped 6 cents a share of Friday to close at $12.47. The company is an international provider of offshore contract oil and gas well drilling services. The problem for Transocean and many offshore drilling companies is that its revenues are being affected by companies that have shifted their focus to shale drilling, which, like offshore drilling, was once thought to be environmentally hazardous. The demand for oil rigs has dropped by more than half since the bottom fell out of the oil market in 2015. When the price of oil began to recover, the demand for offshore rigs did not. When the price of Transocean stock began to recover in late 2016, from $9.79 a share, the stock turned positive. But its recent decline will have to level off if the company expects to avoid falling below that 6 month low. Transocean has reported a net income of $2.1 a share from revenue of $4.16 billion for year 2016.

Access RDI’s Transocean Research Report at: https://ub.rdinvesting.com/news/?ticker=RIG

Our Actionable Research on Seadrill Ltd. (NYSE: SDRL) and Transocean Ltd. (NYSE: RIG) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at
www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 457692

Frontier Communications and Windstream Holdings Tell the Tale of the Importance of High Value Stocks

NEW YORK, NY / ACCESSWIRE / March 20, 2017 /When it comes to stock price, the actual price of the stock can be deceiving. This may sound contradictory, but there are underlying factors that affect the perception of a stock’s value. Frontier Communications has a low stock price but has been sought after by investors. In contrast, many consumers are familiar with Windstream and it exhibits strengths both as a company and as an investment stock. Both stocks are considered to be high yield, but by reading the latest stock movements below you will see that superficial approaches to investing can produce unexpected results.

RDI Initiates
Coverage:

Frontier
Communications Corp. https://ub.rdinvesting.com/news/?ticker=FTR

Windstream Holdings,
Inc. https://ub.rdinvesting.com/news/?ticker=WIN

Frontier Communications stock was down 4 cents a share on Friday to close at $2.47 a share. The company was one of three that were removed from the Standard and Poor’s stock index on March 10th, as the stock exchanged increased its market cap guidelines. The company provides telecommunication services, including video, telephone, and cable services to urban areas. With dividend yield of nearly 17 percent, the company has been considered a good buy for investors who are seeking high yield investments, although its removal from the S&P 500 has sent a warning signal to investors that while the high yield potential is still there, the stock itself is unstable. Its $2.47 closing price is near its 52 week low of $2.31 a share. With net loss of $0.12 a share, higher than consensus estimates of loss of $0.05 a share and slightly lower than expected revenue of $2.41 billion, the company received couple of numbers of downgrades from different research firms, including Bank of America Merrill lynch downgrading it to “Neutral” from “Buy”. Larger no of analysts still maintains “hold” for the company. Over the past 30 days the stock has given up 82 cents a share.

Access RDI’s Frontier Communications Research Report at: https://ub.rdinvesting.com/news/?ticker=FTR

Windstream Holdings bumped up 5 cents a share on Friday to close at $6.28. Investment ratings firms have a variety of positions on the stock, with one firm raising its recommendation on Windstream as a “buy”. The company is beginning to recover from its 52 week low of $6.65 a share. Less than a month ago, Windstream completed merger with Earthlink to expand its network reach. The company’s product offerings include broadband, security solutions, voice, and digital TV channels to consumers. It is a member of the Fortune 500 list of most successful companies. Windstream has reported a net loss of $383.5 million or $4.11 a share on revenue of $5.4 billion for the year 2016 as compared to profit of $27.4 million or $0.24 a share on revenue of $5.77 billion for the year 2015.

Access RDI’s Windstream Holdings Research Report at: https://ub.rdinvesting.com/news/?ticker=WIN

Our Actionable Research on Frontier Communications Corp. (NASDAQ: FTR) and Windstream Holdings, Inc. (NASDAQ: WIN) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at
www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 457691

Update in Lawsuit for Investors in NYSE: ABBV Shares Against AbbVie Inc. Announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / March 20, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending in Illinois on behalf of certain purchasers of (NYSE: ABBV) shares over alleged Securities Laws Violations by AbbVie Inc.

Investors, who purchased shares of AbbVie Inc. (NYSE: ABBV) prior to August 2014 and continue to hold any of those NYSE: ABBV shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On June 20, 2014, AbbVie Inc. confirmed media reports that it had approached another biopharmaceutical company, Shire, with an initial proposal for a merger and on July 18, 2014, AbbVie Inc. disclosed that its Board had agreed to terms for the merger, which was valued at approximately $54 billion.

Then on August 5, 2014, the Treasury Department announced that it was “reviewing a broad range of authorities for possible administrative actions to limit inversions as well as approaches that could meaningfully reduce the tax benefits after inversions took place.” On September 22, 2014, the U.S. Treasury Department issued a notice that it would be taking steps to curb the practice of corporate inversions.

On October 14, 2014, AbbVie Inc. announced that its Board would be reconsidering its recommendation to shareholders to adopt the merger agreement.

On October 15, 2014, Bloomberg published an article stating that “AbbVie’s move surprised investors after the drug company had said the deal was driven mostly by strategic, not tax, reasons.”

On October 20, 2014, AbbVie issued a press release stating that AbbVie and Shire were terminating the merger.

On November 25, 2014, a lawsuit was filed against AbbVie Inc. over alleged securities laws violations. The plaintiff alleges that the defendants materially misrepresented or failed to disclose the following adverse facts that the Combination was based on various strategic rationales, and that the expected tax benefit as a result of reincorporation in Ireland (a practice known as a tax inversion) was “not the primary rationale” for the Combination.

On March 29, 2016, the court granted the defendants’ motion to dismiss, but gave the plaintiffs leave to amend their complaint. On May 2, 2016 an amended complaint was filed by the plaintiffs and on June 16, 2016 the defendants filed their motion to dismiss the amended complaint. On March 10, 2017, the court denied the defendants’ motion to dismiss the case.

Those who purchased shares of AbbVie Inc. (NYSE: ABBV) prior to August 2014 and continue to hold any of those NYSE: ABBV shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 457677

Today’s Research Reports on Stocks to Watch: Geron and Galena Biopharma

NEW YORK, NY / ACCESSWIRE / March 20, 2017 / As both Geron and Galena Biopharma show signs of biotech life with their FDA trial advancements, the stocks also have a common problem – how to convince investors that they are a good investment for the long term. Many biotech stock prices flail around and investors do not know which direction they are headed. This is because the sector consists of a variety of companies that are either bought out or whose FDA Phase 3 trials are insufficient for final FDA approval. Today’s good news can quickly become tomorrow’s reason to sell yesterday. Here are two stocks worth watching for different reasons.

RDI Initiates
Coverage:

Geron Corporation https://ub.rdinvesting.com/news/?ticker=GERN

Galena Biopharma Inc. https://ub.rdinvesting.com/news/?ticker=GALE

Geron Corporation closed up 1 cent a share on Friday, to close at $2.10. After hours trading made no change to the $2.13 mid-afternoon high it saw before dropping down. Geron Corporation is a biotechnology company that focuses on the development of pharmaceuticals and has a very small revenue stream it is generating from collaboration and license fees and royalties as of now. The price swings are an indicator of stock price volatility, and potential takeover rumors. The recent rating given to the stock by Zacks Investment Research has given the company a “buy” rating largely based on its estimated future earnings. The company is categorized as a health services company that is developing treatments for cancer treatments using stem cell research. Geron has reported a loss of $0.19 a share for year 2016.

Access RDI’s Geron Corporation Research Report at: https://ub.rdinvesting.com/news/?ticker=GERN

Galena Biopharma was up 1 cent a share on Friday to close at 63 cents per share. The company’s lead candidate drug is GALE-301, a cancer immunotherapy drug intended to be used for the prevention of ovarian cancer recurrence and endometrial cancer in patients. Bijan Nejadnik, M.D., the company’s Executive Vice President and Chief Medical Officer said during a Friday presentation of the FDA Phase 1 and 2 results, “This final data from our early stage clinical trial demonstrates that GALE-301 is well tolerated and we were able to obtain statistically significant disease free survival in a small number of patients treated with the optimal dose.” The statement came as positive news for investors, but were reminded of at least one pending litigation filed by investors in April of last year. Galena has reported a net loss of $0.49 a share and $2.36 a share for the fourth quarter and full year of 2016 respectively.

Access RDI’s Galena Biopharma Research Report at: https://ub.rdinvesting.com/news/?ticker=GALE

Our Actionable Research on Geron Corporation (NASDAQ: GERN) and Galena Biopharma Inc. (NASDAQ: GALE) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at
www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 457694

Lawsuit for Investors in NYSE: HCP Shares Against HCP, Inc. Announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / March 20, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending in Ohio for certain purchasers of shares of HCP, Inc. (NYSE: HCP) over alleged Securities Laws Violations by HCP, Inc.

Investors, who purchased shares of HCP, Inc. in February 2015 or earlier and currently hold any of those NYSE: HCP shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779-554.

The lawsuit was originally filed in May 2016, and is currently pending against HCP, Inc. The plaintiff alleged that the defendants violated Federal Securities Laws by issuing allegedly false and misleading press releases, financial statements, filings with the U.S. Securities and Exchange Commission (“SEC”), and statements during investor conference calls. More specifically, the plaintiff alleged that HCP Inc. was highly dependent upon the operations of ManorCare, a nursing home operator, which served as HCP Inc.’s most significant client, that prior to March 2015 HCP Inc. invested directly in ManorCare, purchasing substantially all of ManorCare’s real estate facilities (which were then leased back to ManorCare) and taking a 10% equity stake in ManorCare, and that as a result of that transaction, ManorCare had a significant impact on several aspects of HCP Inc.’s operations and was highly important to HCP Inc. investors.

The plaintiff claims that the defendants misrepresented ManorCare’s financial performance, the value of HCP Inc.’s ManorCare assets, and that HCP Inc.’s revenue stream from ManorCare leases was secure. Moreover, HCP Inc. and ManorCare represented that ManorCare had “a long history of compliance with regulations,” and that ManorCare’s billing practices had been “audited” in the past and were “to the standard one would want,” and that as result of these misrepresentations, HCP Inc. common stock traded at allegedly artificially inflated prices between March 30, 2015 and February 8, 2016.

The plaintiff alleged that the defendants knew or recklessly disregarded that ManorCare was engaged in rampant billing fraud, which allegedly generated false claims for “reimbursement” submitted to government programs. ManorCare’s billing fraud was the subject of multiple whistleblower lawsuits, and an investigation by the United States Department of Justice (“DOJ”).

Those who purchased shares of HCP, Inc. in February 2015 or earlier and currently hold any of those NYSE:HCP shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 457678

Research Reports Initiated on Chemicals Stocks Methanex, EcoSynthetix, and Argex Titanium

LONDON, UK / ACCESSWIRE / March 20, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Basic Materials sector/ Chemicals industry. Companies recently under review include Methanex, EcoSynthetix, and Argex Titanium.

http://www.activewallst.com/register/

At the closing bell on Friday, March 17, 2017, the Toronto Exchange Composite index edged 0.46% lower to finish the trading session at 15,490.49 with a total volume of 715,382,343 shares exchanging hands for the day.

Active Wall St. has initiated research reports on the following equities: Methanex Corporation (TSX: MX), EcoSynthetix Inc. (TSX: ECO), and Argex Titanium Inc. (TSX: RGX). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Methanex Corp.

Vancouver, Canada headquartered Methanex Corp.’s stock edged 0.99% lower, to finish Friday’s session at $62.05 with a total volume of 490,020 shares traded. Over the last one month and the previous three months, Methanex’s shares have advanced 1.77% and 1.62%, respectively. Shares of the Company, which produces and supplies methanol in the Asia Pacific, North America, Europe, and South America, are trading above its 200-day moving average. Methanex’s 50-day moving average of $65.34 is above its 200-day moving average of $55.41. See our research report on MX.TO at:

http://www.activewallst.com/register/

EcoSynthetix Inc.

On Friday, shares in Burlington, Canada headquartered EcoSynthetix recorded a trading volume of 13,702 shares. The stock ended the day 2.63% higher at $2.73. EcoSynthetix’s stock has gained 22.42%, both in the last one month and in the previous three months. Furthermore, the stock has rallied 157.55% in the past one year. Shares of the Company, which engages in the development and commercialization of bio-based materials in the Americas, Europe, Middle East, Africa, and Asia/Pacific, are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $2.27 is above its 200-day moving average of $2.21. The complimentary research report on ECO.TO at:

http://www.activewallst.com/register/

Argex Titanium Inc.

On Friday, shares in Laval, Canada-based Argex Titanium Inc. ended the session flat at $0.08 with a total volume of 116,000 shares traded. Argex Titanium’s shares have surged 33.33% in the last three months and 100.00% in the previous one year. Shares of the Company, which produces titanium dioxide in Canada, are trading above its 50-day moving average of 0.07%. Register for free and access the latest research report on RGX.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 457679